Related Research Articles
Internal medicine, also known as general internal medicine in Commonwealth nations, is a medical specialty for medical doctors focused on the prevention, diagnosis, and treatment of internal diseases in adults. Medical practitioners of internal medicine are referred to as internists, or physicians in Commonwealth nations. Internists possess specialized skills in managing patients with undifferentiated or multi-system disease processes. They provide care to both hospitalized (inpatient) and ambulatory (outpatient) patients and often contribute significantly to teaching and research. Internists are qualified physicians who have undergone postgraduate training in internal medicine, and should not be confused with "interns", a term commonly used for a medical doctor who has obtained a medical degree but does not yet have a license to practice medicine unsupervised.
Bronchoalveolar lavage (BAL), also known as bronchoalveolar washing, is a diagnostic method of the lower respiratory system in which a bronchoscope is passed through the mouth or nose into an appropriate airway in the lungs, with a measured amount of fluid introduced and then collected for examination. This method is typically performed to diagnose pathogenic infections of the lower respiratory airways, though it also has been shown to have utility in diagnosing interstitial lung disease. Bronchoalveolar lavage can be a more sensitive method of detection than nasal swabs in respiratory molecular diagnostics, as has been the case with SARS-CoV-2 where bronchoalveolar lavage samples detect copies of viral RNA after negative nasal swab testing.
The Infectious Diseases Society of America (IDSA) is a medical association representing physicians, scientists, and other healthcare professionals who specialize in infectious diseases. It was founded in 1963 and is based in Arlington, Virginia. As of 2018, IDSA had more than 11,000 members from across the United States and nearly 100 other countries on six different continents. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. It is a 501(c)(6) organization.
The Emerging Pathogens Institute (EPI) is an interdisciplinary research institution associated with the University of Florida. The institute focuses on fusing key disciplines to develop outreach, education, and research capabilities designed to preserve the region's health and economy, as well as to prevent or contain new and re-emerging diseases. Researchers within the institute work in more than 30 different countries around the world, with over 250 affiliated faculty members stemming from 11 University of Florida colleges, centers, and institutes. The 90,000-square-foot building includes laboratories and collaborative space for bioinformatics and mathematical modeling.
Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.
Luciana Borio is a Brazilian-American infectious disease physician and public health administrator. She is a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council, acting chief scientist of the U.S. Food and Drug Administration (FDA), assistant commissioner for counterterrorism policy of the FDA, and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials, the development of medical countermeasures for health emergencies, and the public health responses to Ebola and Zika outbreaks.
Dale Andrew Fisher FRACP is an infectious diseases physician who specialises in Infectious Diseases and a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore, and the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore. In 2020, he became group chief of Medicine for National University Health Systems.
Syra Madad is an American pathogen preparedness expert and infectious disease epidemiologist. Madad is the Senior Director of the System-wide Special Pathogens Program at NYC Health + Hospitals where she is part of the executive leadership team which oversees New York City's response to the Coronavirus disease 2019 pandemic in the city's 11 public hospitals. She was featured in the Netflix documentary series Pandemic: How to Prevent an Outbreak and the Discovery Channel documentary The Vaccine: Conquering COVID.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
Colleen S. Kraft is an infectious disease physician, associate professor in the Department of Pathology and Laboratory Medicine, and the director of the Clinical Virology Research Laboratory at Emory University School of Medicine. In 2014, she led Emory University Hospital's effort to treat and care for Ebola virus disease patients and is currently working to address the COVID-19 pandemic in Georgia. She currently serves on Georgia's COVID-19 task force.
Carolyn S. Calfee is a Professor of Medicine and Anaesthesia at the University of California, San Francisco. She works in intensive care at the UCSF Medical Center where she specialises in acute respiratory distress syndrome. During the COVID-19 pandemic Calfee studied why SARS-CoV-2 patients experienced such different symptoms.
Müge Çevik is a physician who is an infectious diseases researcher and science communicator at the University of St Andrews. Her research considers HIV, viral hepatitis, emerging infections and tropical infections in developing countries. During the COVID-19 pandemic, Çevik was an advisor to the Chief Medical Officer of Scotland and the World Health Organization, and is a member of New and Emerging Respiratory Virus Threats Advisory Group - an expert committee of the UK Department of Health advising Scientific Advisory Group for Emergencies.
Science diplomacy is the collaborative efforts by local and global entities to solve global issues using science and technology as a base. In science diplomacy, collaboration takes place to advance science but science can also be used to facilitate diplomatic relations. This allows even conflicting nations to come together through science to find solutions to global issues. Global organizations, researchers, public health officials, countries, government officials, and clinicians have previously worked together to create effective measures of infection control and subsequent treatment. They continue to do so through sharing of resources, research data, ideas, and by putting into effect laws and regulations that can further advance scientific research. Without the collaborative efforts of such entities, the world would not have the vaccines and treatments we now possess for diseases that were once considered deadly such as tuberculosis, tetanus, polio, influenza, etc. Historically, science diplomacy has proved successful in diseases such as SARS, Ebola, Zika and continues to be relevant during the COVID-19 pandemic today.
Sylvie Champaloux Briand is a French physician who is Director of the Pandemic and Epidemic Diseases Department at the World Health Organization. Briand led the Global Influenza Programme during the 2009 swine flu pandemic. During the COVID-19 pandemic, Briand launched the WHO Information Network for Epidemics which looked to counter the spread of COVID-19 misinformation.
The treatment and management of COVID-19 combines both supportive care, which includes treatment to relieve symptoms, fluid therapy, oxygen support as needed, and a growing list of approved medications. Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the estimated millions of immunocompromised persons who are unlikely to respond robustly to vaccination, treatment remains important. Some people may experience persistent symptoms or disability after recovery from the infection, known as long COVID, but there is still limited information on the best management and rehabilitation for this condition.
Long COVID or long-haul COVID is a group of health problems persisting or developing after an initial period of COVID-19 infection. Symptoms can last weeks, months or years and are often debilitating. The World Health Organization defines long COVID as starting three months after the initial COVID-19 infection, but other agencies define it as starting at four weeks after the initial infection.
Lyda Elena Osorio Amaya is a Colombian physician, epidemiologist and infectious disease specialist. She is an associate professor at the Universidad del Valle, and a researcher at the Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) in Cali, Valle del Cauca. Osorio's research has focused mainly on vector-borne diseases like malaria, leishmaniasis, Zika and dengue fever. She has also played a role in Colombia's response against COVID-19.
Amesh Adalja is an American infectious disease physician. He specializes in infectious disease, bioterrorism, and emergency medicine at Johns Hopkins Center for Health Security and a clinical assistant professor at the University of Pittsburgh School of Medicine.
Jane Eddleston is a British medical doctor, professor and critical care consultant at Manchester Royal Infirmary. In 2022 she became the first woman doctor to win the Faculty of Intensive Care Medicine Gold Medal.
References
- ↑ "ERGO & ISARIC". Nuffield Department of Medicine . Archived from the original on 2022-10-04. Retrieved 2022-10-04.
- 1 2 "Membership". ISARIC. Archived from the original on 2022-10-04. Retrieved 2022-10-04.
- 1 2 "ISARIC COVID-19 clinical database passes the half million patient records mark". ISARIC. 2021-07-16. Archived from the original on 2022-10-04. Retrieved 2022-10-04.
- 1 2 Docherty, Annemarie; Semple, Callum. "Collecting COVID-19 data and samples in a way that enables global research (ISARIC-CCP project)". Health Data Research UK. Archived from the original on 2022-01-20. Retrieved 2022-10-05.
- ↑ Dunning, Jake W.; Merson, Laura; Rohde, Gernot G. U.; Gao, Zhancheng; Semple, Malcolm G.; Tran, Dat; Gordon, Anthony; Olliaro, Piero L.; Khoo, Saye H.; Bruzzone, Roberto; Horby, Peter; Cobb, J. Perren; Longuere, Kajsa-Stina; Kellam, Paul; Nichol, Alistair (2014-01-01). "Open source clinical science for emerging infections". The Lancet Infectious Diseases. 14 (1): 8–9. doi:10.1016/S1473-3099(13)70327-X. ISSN 1473-3099. PMC 7158987 . PMID 24355025.
- ↑ "Fellowships". ISARIC. Archived from the original on 2022-10-04. Retrieved 2022-10-04.
- ↑ ISARIC Clinical Characterisation Group; Baillie, J. Kenneth; Baruch, Joaquin; Beane, Abigail; Blumberg, Lucille; Bozza, Fernando Augusto; Broadley, Tessa; Burrell, Aidan; Carson, Gail; Citarella, Barbara Wanjiru; Dunning, Jake; Elotmani, Loubna; Barrio, Noelia Garcia; Goffard, Jean-Christophe; Goncalves, Bronner (2022-04-13). "ISARIC COVID-19 Clinical Data Report issued: 27 March 2022". medRxiv 10.1101/2020.07.17.20155218v1 .
- ↑ "ISARIC COVID-19 clinical database passes ½ million patient records mark". University of Oxford . 2021-07-16. Archived from the original on 2022-01-28. Retrieved 2022-10-04.
- ↑ Docherty, Annemarie B.; Harrison, Ewen M.; Green, Christopher A.; Hardwick, Hayley E.; Pius, Riinu; Norman, Lisa; Holden, Karl A.; Read, Jonathan M.; Dondelinger, Frank; Carson, Gail; Merson, Laura; Lee, James; Plotkin, Daniel; Sigfrid, Louise; Halpin, Sophie (2020-05-22). "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study". BMJ. 369: m1985. doi:10.1136/bmj.m1985. ISSN 1756-1833. PMC 7243036 . PMID 32444460.
- ↑ "Home". ISARIC4C (Comprehensive Clinical Characterisation Collaboration). Archived from the original on 2022-09-01. Retrieved 2022-10-04.
- ↑ Puhan, Milo A.; Sadatsafavi, Mohsen (2022-06-01). "Validation of the 4C prediction models to inform care for patients with COVID-19: final steps towards clinical application". Thorax. 77 (6): 536. doi: 10.1136/thoraxjnl-2021-218313 . ISSN 0040-6376. PMID 35110368. S2CID 246486784.